116.50p+0.00 (+0.00%)04 Jul 2025, 17:15
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Diaceutics PLC Fundamentals

Company NameDiaceutics PLCLast Updated2025-07-04
IndustryHealth Information ServicesSectorHealthcare
Shares in Issue84.547 mMarket Cap£98.50 m
PE Ratio129.87Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0218Debt Equity Ratio0.0228
Asset Equity Ratio1.2199Cash Equity Ratio0.3197
Quick Ratio3.5679Current Ratio3.80
Price To Book Value2.4710ROCE0

Diaceutics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Diaceutics PLC Company Financials

Assets202420232022
Tangible Assets£1.68 m£1.90 m£2.09 m
Intangible Assets£15.41 m£15.26 m£15.22 m
Investments000
Total Fixed Assets£19.09 m£18.30 m£17.36 m
Stocks000
Debtors£14.96 m£10.13 m£8.58 m
Cash & Equivalents£12.74 m£16.67 m£19.84 m
Other Assets000
Total Assets£48.62 m£46.34 m£48.26 m
Liabilities202420232022
Creditors within 1 year£7.76 m£4.38 m£3.75 m
Creditors after 1 year£998,000.00£1.18 m£1.99 m
Other Liabilities000
Total Liabilities£8.76 m£5.56 m£5.74 m
Net assets£39.86 m£40.79 m£42.51 m
Equity202420232022
Called up share capital£170,000.00£169,000.00£169,000.00
Share Premium0£37.13 m£37.13 m
Profit / Loss-£1.91 m-£2.44 m£564,000.00
Other Equity£39.86 m£40.79 m£42.51 m
Preference & Minorities000
Total Capital Employed£39.86 m£40.79 m£42.51 m
Ratios202420232022
Debt Ratio£0.02£0.03£0.03
Debt-to-Equity£0.02£0.03£0.03
Assets / Equity1.21991.21991.2199
Cash / Equity0.31970.31970.3197
EPS-£0.02-£0.02£0.01
Cash Flow202420232022
Cash from operating activities£651,000.00£1.31 m£5.10 m
Cashflow before financing£587,000.00£1.07 m£4.91 m
Increase in Cash-£3.44 m-£3.14 m£146,000.00
Income202420232022
Turnover£32.16 m£23.70 m£19.50 m
Cost of sales£3.89 m£3.99 m£2.76 m
Gross Profit£28.27 m£19.71 m£16.74 m
Operating Profit-£2.46 m-£3.02 m£575,000.00
Pre-Tax profit-£1.91 m-£2.44 m£564,000.00

Diaceutics PLC Company Background

SectorHealthcare
ActivitiesDiaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives. Geographically, it operates in UK, North America, Europe, and Asia and Rest of World.
Latest Interim Date17 Sep 2024
Latest Fiscal Year End Date13 May 2025

Diaceutics PLC Directors

AppointedNamePosition
2025-05-21Mr. Michael Wort Non-Executive Director
2024-05-29Mr. Charles Hindson Non-Executive Director
2025-05-21Mr. Graham Douglas PatersonNon-Executive Director,Senior Independent Director
2024-10-01Ms. Deborah Lee DavisNon-Executive Director,Chairman
2020-12-22Ms. Julie Goonewardene Wallin Non-Executive Director,Chairman
2025-05-21Mr. Peter KeelingNon-Executive Director,Chairman
2025-05-21Mr. Ryan Keeling Executive Director,Chief Executive Officer
2022-03-18Mr. Philip White FCAExecutive Director,Chief Financial Officer
2025-06-30Mr. Nicholas Stewart RobertsExecutive Director,Chief Financial Officer
2025-06-30Mr. Jordan Russell ClarkExecutive Director,Chief Data Officer

Diaceutics PLC Contact Details

Company NameDiaceutics PLC
Address55-59 Adelaide Street, Titanic Suites, Enterprise House, Antrim, BT2 8FE
Telephone
Websitehttps://www.diaceutics.com

Diaceutics PLC Advisors